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Epidermal Growth Factor Receptor Pathway
Mitigates UVA-Induced G2/M Arrest in Keratinocyte
Cells
Christine Jean1,4, He´le`ne Hernandez-Pigeon1,2,4, Amandine Blanc1, Marie Charveron2 and Guy Laurent1,3
UVA irradiation contributes largely to photocarcinogenesis. In the process of keratinocyte transformation, the
activation of EGFR by UV is now considered as a critical event. However, the mechanism that links the EGFR
pathway and photocarcinogenesis is not totally understood. In this study, we report that the EGFR/Akt pathway
mitigated G2/M arrest in human HaCaT keratinocytes and normal human keratinocytes treated with low doses
of UVA irradiation. EGFR-mediated Akt activation resulted in increased level of checkpoint 1 kinase (Chk1)
inhibitory phosphorylation (Ser280). In contrast, EGFR/Akt pathway inhibition resulted in the abrogation of
Ser280 Chk1 phosphorylation, increased level of Chk1 stimulatory phosphorylation (Ser345), and restoration of
G2/M arrest. Altogether, these results suggest that, after UVA exposure, the EGFR/Akt pathway subverts the G2/
M checkpoint. This effect may have serious implications in photocarcinogenesis by allowing damaged cells to
transit through the cell cycle.
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INTRODUCTION
UVA (320–400 nm) constitutes about 95% of natural sunlight-
associated UV irradiation and plays an important role in
photocarcinogenesis (Agar et al., 2004; He et al., 2006) by
creating DNA damage mainly consisting of pyrimidine dimer
accumulation and base oxidation (Phillipson et al., 2002;
Rochette et al., 2003).
The mechanism that links DNA damage and photocarcino-
genesis results from a variety of molecular events that integrate
cell death and survival signals, DNA repair, and mutagenesis.
Among these complex networks, the activation of the EGFR
appears to play a central role. As a matter of fact, previous
studies indicated not only that UVA activates EGFR (He et al.,
2004), but also that genetic ablation of EGFR reduces UV-
induced skin tumors in mice (El-Abaseri et al., 2005).
The mechanism by which EGFR contributes to photo-
carcinogenesis is not totally understood. Previous studies
have suggested a role for EGFR-mediated activation of
survival pathways, implicating mitogen-activated protein
kinase (MAPK) and phosphatidylinositol 3-kinase pathways,
both involved in mitogenesis and apoptosis inhibition.
Accordingly, a recent study suggested that EGFR activation
promotes skin tumorigenesis by suppressing cell death,
augmenting cell proliferation, and accelerating epidermal
hyperplasia in response to UV (El-Abaseri et al., 2005, 2006).
However, it is likely that EGFR activation mediates other
events that may also contribute to keratinocyte transforma-
tion.
As a putative distinct mechanism, we raised the possibility
that the EGFR pathway could also interfere with cell-cycle
control after UV exposure. Indeed, like other genotoxic
stresses, UVA exposure causes either G1/S arrest to prevent
replication of damaged DNA or G2/M arrest to prevent
segregation of damaged chromosomes during mitosis (Ny-
berg et al., 2002; Sancar et al., 2004). The G1/S checkpoint is
mainly under the control of p53 through the Cdk inhibitor
p21. G2/M arrest is largely dependent on the checkpoint 1
kinase (Chk1)-mediated signaling pathway leading to inhibi-
tion of cyclin B1/Cdc2 activity. Chk1, a serine/threonine
kinase, is activated by phosphorylation on Ser317 and Ser345
by the DNA damage-activated ataxia-telangiectasia-mutated
(ATM) and ATM- and Rad3-related (ATR) kinases (Nyberg
et al., 2002; Bartek and Lukas, 2003). Chk1 activation results
in a complex signaling cascade consisting of the following
events: interaction of Chk1 with CDC25C, phosphorylation of
this enzyme on the Ser216 residue, association of CDC25C
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with 14-3-3 protein, and sequestration of this complex in the
cytoplasm (Peng et al., 1997). As Cdc25C plays a critical role
in reversal of inhibitory phosphorylation of Cdc2 on Tyr15
and Thr14 (Jessus and Ozon, 1995), the blockage of its
activity inhibits activation of cyclin B1/Cdc2 activity required
for the G2/M transition. In this study, we evaluated the
influence of the EGFR pathway on the G2/M arrest in p53-
deficient keratinocytes (HaCaT cells) and in normal human
keratinocytes (NHKs) following low doses of UVA irradiation.
RESULTS
Influence of EGFR on UVA-induced G2/M arrest and survival in
HaCaT cells
UVA did not induce cell-cycle arrest up to 150 kJ/m2 in
untreated cells as judged by propidium iodide (PI) staining by
flow cytometry (Figure 1a, left column). However, when cells
were pretreated with an EGFR inhibitor, tyrphostin AG1478
(N-(3-chlorophenyl)-6,7-dimethoxy-4-quinazolinamine) (Fig-
ure 1a, right column), G2/M arrest was detected for doses as
low as 20 kJ/m2 in cells. For example, at the dose of 40 kJ/m2 ,
the cell fraction blocked at G2/M was 38.5671.24 and
16.8772.44% in AG1478-treated cells and control cells,
respectively. For controls, we checked that pretreatment with
AG1478 without any irradiation did not induce cell-cycle
arrest (Figure 1a). Moreover, UVA (40 kJ/m2) induced an
AG1478-inhibitable increase in EGFR tyrosine phosphoryla-
tion in HaCaT cells as judged by immunoprecipitation with
anti-phosphotyrosine Ab, whereas EGFR expression re-
mained unchanged (data not shown).
To strengthen the specificity of EGFR in the regulation of
UVA-induced cell-cycle arrest, we used small interfering
RNA (siRNA) directed against EGFR. As expected from the
previous experiments, we found that, after UVA exposure,
EGFR depletion (see Figure 1b) resulted in the restoration of
G2/M arrest with 38.6671.99% versus 20.9770.48%
arrested in G2/M in siEGFR-transfected cells and in
scrambled-transfected cells, respectively (Figure 1c).
In additional experiments, we evaluated the impact of
EGFR inhibition and subsequent G2/M restoration on cell
survival. Pretreatment with AG1478 resulted in a significant
dose-dependent increase in the sub-G1 cell fraction in
irradiated HaCaT cells (Figure 1d), suggesting that the
alleviation of G2/M control due to EGFR pathway inhibition
protected cells from apoptosis. Moreover, after UVA ex-
posure (40 kJ/m2), HaCaT cells proliferated during a 96-hour
period, with a doubling time as high as 48 hours (vs 36 hours
for nonirradiated cells). However, when pretreated with
AG1478, the proliferation of irradiated cells was inhibited
much more strongly (Figure 1e).
These results suggest that the EGFR pathway inhibits G2/M
control and, through this mechanism, allows cells to survive
and proliferate.
Influence of Akt on UVA-induced G2/M arrest in HaCaT cells
Because Akt is a major target of EGFR (Zhang et al., 2001),
we then tested the influence of Akt in the EGFR-mediated
repression of G2/M arrest after UVA irradiation. The
phosphorylation profile of Akt was first examined. In
unstimulated cells, we found that Akt is phosphorylated at
Thr308 (data not shown) and Ser473 (Figure 2a) and that EGF
induced an increase in Akt phosphorylation level at the two
sites. After irradiation, Akt phosphorylation increased through
an EGFR-dependent mechanism, as attested by the inhibitory
effect of AG1478 (Figure 2a). Akt depletion by siRNA (see
Figure 2b) resulted in the restoration of G2/M arrest after UVA
exposure, as shown in Figure 2c, at a dose of 40 kJ/m2
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Figure 1. Influence of EGFR on UVA-induced G2/M arrest. (a) HaCaT cells
were pretreated or not (NT) with AG1478 (10 mM) for 1 hour before UVA
irradiation or without irradiation (NI). Different doses of UVA irradiation were
used, from 10 to 150 kJ/m2. Cell cycle was analyzed by flow cytometry
16 hours after irradiation. Histograms of flow-cytometric analysis show the
cell cycle of the survival population. These data are the means of three
independent experiments. *Po0.05 and **Po0.01. (b–c) HaCaT cells were
transfected with scrambled or EGFR siRNA. (c) Western blot shows EGFR
expression 48 hours after transfection. b-Actin was used as a loading control
for Western blot. (d) HaCaT cells were pretreated (’) or not (&) with
AG1478 (10 mM) for 1 hour before UVA irradiation or without irradiation.
Different doses of UVA irradiation were used, from 10 to 60 kJ/m2. Cell cycle
was analyzed by flow cytometry 16 hours after irradiation. Histograms of
flow-cytometric analysis show the cell cycle of the percentage of sub-G1 cells.
(e) HaCaT cells were pretreated (n) or not (&) by AG1478 and then irradiated
(black) or not (white) at 40 kJ/m2. Cell number was estimated by trypan blue
exclusion assay. These data are representative of three independent
experiments.
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(39.8672.64% G2/M cells and 20.7871.08% G2/M cells
when treated with siRNA and scrambled RNA, respectively).
This result suggests that Akt mediates the inhibitory effect
of EGFR on UVA-induced G2/M arrest.
Influence of the EGFR/Akt pathway on Chk1 phosphorylation
profile in HaCaT cells
On the basis of the premier role of Chk1 activity on the
regulation of stress-induced G2/M arrest, we hypothesized
that the EGFR/Akt pathway could interfere with Chk1
phosphorylation. This hypothesis was supported by previous
studies, which described that, at least under certain
circumstances (King et al., 2004), Akt may interact with
Chk1 and phosphorylate this kinase on the Ser280 residue,
resulting in Chk1 inhibition (Puc and Parsons, 2005).
In nonirradiated cells, Chk1 phosphorylation on Ser317
(data not shown) and Ser345 (Figure 3a) (stimulatory
phosphorylation sites) was almost undetectable, whereas a
nonnegligible level of phosphorylation on Ser280 (inhibitory
phosphorylation site) was found (Figure 3a, lane 1). The latter
observation is most likely due to Akt basal activity as
described in Figure 2a. EGF induced an AG1478-inhibitable
stimulation of phosphorylation at the Ser280 site, compared
with unstimulated cells, but had no effect on Ser345
phosphorylation (Figure 3a, lane 3).
In irradiated cells, we found that, in the absence of
AG1478, UVA increased Chk1 phosphorylation on the
Ser280 site, whereas the phosphorylation level of Ser345
remained undetectable (Figure 3b). The increase in Ser280
phosphorylation was time-dependent and peaked at 1 hour
(Figure 3b). In contrast, AG1478-mediated EGFR inhibition
resulted in total inhibition of Ser280 phosphorylation as well
as a significant increase in the phosphorylation of Chk1 at
Ser345 (Figure 3b).
Although this finding strongly suggested that the EGFR
pathway interfered directly at the Chk1 level, we have also
investigated the possible, although never documented,
impact of EGFR upstream of Chk1, namely on ATM or ATR
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Figure 2. Influence of Akt on UVA-induced G2/M arrest. (a) HaCaT cells
were pretreated or not with AG1478 (10mM) for 1 hour before EGF treatment
(100 ng/ml). Cells were then incubated for 1 hour and Western-blot analysis
was performed using anti-phospho-Ser473 Akt and Akt Abs. HaCaT cells were
transfected with scrambled or Akt siRNA. (b) Western blot shows Akt and
phosphoserine 473 (P473) Akt expression 48 hours after transfection. b-Actin
was used as a loading control for Western blot. (c) HaCaT cells were then
irradiated or not at 40 kJ/m2 and cell-cycle analysis was performed 16 hours
after irradiation. These data are representative of three independent
experiments.
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Figure 3. Influence of the EGFR/Akt pathway on Chk1 phosphorylation
profile. (a) HaCaT cells were pretreated or not with AG1478 (10mM) for
1 hour before EGF treatment (100 ng/ml) for 1 hour. Western-blot analysis was
performed using anti-phospho-Ser345 (P345) and anti-phospho-Ser280
(P280) Chk1 and anti-Chk1 Abs. (b) HaCaT cells were pretreated or not with
AG1478 (10 mM) for 1 hour before UVA irradiation at 40 kJ/m2. Cells were
then incubated for various times and Western-blot analysis was performed
using anti-phospho-Ser345 and anti-phospho-Ser280 Chk1 and anti-Chk1
Abs. (c) HaCaT cells were transfected with scrambled or Akt siRNA. Forty-
eight hours after transfection, cells were irradiated at 40 kJ/m2 and incubated
for 1 hour before Western-blot analysis performed using anti-phospho-Ser345
and anti-phospho-Ser280 Chk1 and anti-Chk1 Abs. (d) HaCaT cells were
pretreated or not with AG1478 (10 mM) for 1 hour before UVA irradiation at
40 kJ/m2. Cells were then incubated for 1 or 3 hours. Western-blot analysis
was performed using anti-phospho-Thr68 (P68) Chk2 and anti-Chk2 Abs.
These data are representative of three independent experiments.
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activation. As expected, UVA irradiation resulted in the
activation of both ATM and ATR proteins (data not shown).
However, EGFR inhibition by AG1478 had no influence on
ATM or ATR activation (data not shown). These results
reinforced the notion that, along the ATM/ATR–CHK1 axis,
the EGFR pathway acted at the Chk1 level.
The Chk1 phosphorylation profile was also found to be
strongly influenced by Akt expression level. Indeed, as
illustrated in Figure 3c, Akt depletion by siRNA in UVA-
treated cells resulted in decreased Chk1 phosphorylation at
Ser280 and increased phosphorylation at Ser345, thus
mimicking the effect of AG1478. Because of redundancies
between Chk1 and Chk2 in G2/M control and the fact that the
latter is also a substrate for Akt (Hirose et al., 2005), we
evaluated the Chk2 phosphorylation profile in HaCaT cells
treated with or without AG1478. However, we detected no
differences in Chk2 phosphorylation on the Thr68 residue, a
specific site for Akt (Figure 3d).
These results suggest a model in which the UVA-activated
EGFR/Akt pathway targets Chk1 directly by facilitating
Ser280 inhibitory phosphorylation. Subsequently, Chk1
inhibition is responsible for G2/M block attenuation, allowing
the cell to transit through G2/M and proliferate.
Influence of MAPK activities on Chk1 phosphorylation profile
UVA irradiation activates a large variety of signaling path-
ways, including c-Jun N-terminal kinases, extracellular
signal-regulated kinases, and p38 MAPK modules (Hernan-
dez-Pigeon et al., 2007). Among the different MAPK
modules, we have especially considered the role of
MAPKAPK-2, a substrate for p38MAPK, because this kinase
has been shown to interfere with G2/M control both under
basal conditions and in the context of UV irradiation (Manke
et al., 2005). Accordingly, we used MAPK inhibitors to
investigate whether these signaling pathways could interfere
with the Chk1 phosphorylation profile (Ser280 and Ser345)
and with cell-cycle regulation. As shown in Figure 4,
SB203580, a specific p38MAPK inhibitor; SP600125, a c-
Jun N-terminal kinase inhibitor; and PD980159, an extra-
cellular signal-regulated kinase inhibitor have no impact,
neither on the Chk1 phosphorylation profile (Figure 4a) nor
on cell-cycle changes (Figure 4b), in HaCaT cells treated at
40 kJ/m2.
These results suggest that MAPKs do not interfere with
UVA-mediated Chk1 regulation.
Influence of EGFR on UVA-induced G2/M arrest in NHKs
In further experiments, we investigated whether Chk1
regulation by the EGFR/Akt pathway is also functional in
NHKs. Although NHK cells were found to be more sensitive
to UVA than HaCaT cells, we found that the EGFR signaling
operated in a similar fashion in the two cellular models.
Indeed, UVA induced no cell-cycle arrest in untreated cells
up to 40 kJ/m2. However, pretreatment with AG1478 resulted
in a G2/M arrest that was detectable for doses as low as 10 kJ/
m2. Thus, after pretreatment of NHK cells with the EGFR
inhibitor, 33.4673.10% of cells were at G2/M at the dose of
40 kJ/m2 versus 17.0071.04% in nonpretreated cells. As in
HaCaT cells, UVA induces an EGFR-dependent Akt activa-
tion (Figure 5b) and Chk1-inhibitory phosphorylation
(Ser280) (Figure 5c), whereas EGFR inhibition resulted in
the restoration of Chk1-active phosphorylation (Ser345)
(Figure 5c).
DISCUSSION
This study reports that, after UVA irradiation, the EGFR
pathway mitigates G2/M cell arrest by modulating Chk1
phosphorylation and function through Akt. The fact that
EGFR inhibition restored a functional ATM/ATR–Chk1 axis
and subsequent G2/M block strongly suggests that cells
undergo a relatively high level of DNA damage, which
should have been repaired before entry into mitosis. Thus, it
is likely that cells that transit through mitosis under these
conditions harbored persistent DNA damage. Under these
conditions, the fact that these cells continued to proliferate
represents an intriguing observation. These observations
raised several interesting, although highly speculative,
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Figure 4. Influence of MAPK on cell-cycle arrest. (a) HaCaT cells were
pretreated or not with AG1478 (10mM), SB203580 (1 mM), SP600125 (5 mM),
or PD98059 (10 mM) for 1 hour before UVA irradiation at 40 kJ/m2. Cells were
then incubated for 1 hour. Western-blot analysis was performed using anti-
phospho-Ser345 and anti-phospho-Ser280 Chk1 and anti-Chk1 Abs. (b)
HaCaT cells were pretreated or not (NT) with SB203580 (1 mM), SP600125
(5 mM), or PD98059 (10 mM) for 1 hour before UVA irradiation at 40 kJ/m2 or
without irradiation (NI). Cell cycle was analyzed by flow cytometry 16 hours
after irradiation. Histograms of flow-cytometric analysis show the cell cycle of
the survival population. These data are representative of three independent
experiments.
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hypotheses. First, it is possible that, beyond the first cycle,
DNA damage is repaired through other mechanisms, thus
preventing mutagenic risk. Second, it is possible that, after a
longer period of time, other delayed-action signaling path-
ways operate to reorient the cellular response to proliferation
inhibition and delayed cell death, such as premature
senescence, a modality of cell response that has been largely
documented in the context of UV exposure (Toussaint et al.,
2002). In this case, unless cells escape to senescence,
eventually by losing some critical regulators such as p53,
this modality of long-term response could also reduce the risk
of transformation. Third, it is possible that the cell control
machinery durably neglects this level of DNA damage. If this
is the case, in the context of chronic UVA exposure, it is
conceivable that DNA damage accumulation may facilitate
mutagenesis. This risk could also be increased when cells are
simultaneously exposed to UVA and UVB, such as in the case
of solar irradiation, since under these circumstances, by
inhibiting an important cell-cycle checkpoint, UVA could
facilitate the transit of cells with even more severe
(clastogenic) DNA damage. Thus, it is possible that the
impact of EGFR on Chk1 function is an important component
of the mutagenic properties of the EGFR pathway in the
context of photocarcinogenesis.
Our study shows that the EGFR pathway acts similarly in
NHK and in p53-deficient HaCaT cells, suggesting that this
mechanism operates independent of p53 status. The experi-
ments conducted with the p53-proficient NHK revealed no
G1 block, whereas the ATR/ATM–Chk1 axis was activated for
very low doses of UVA irradiation, even if Chk1 function was
indeed subverted. This observation suggests that the ATR/
ATM–Chk1 axis is the premium cellular control in the context
of low doses of UVA irradiation. This interpretation is in
agreement with a recent study that shows that, if p53 is
indeed activated by UVA in skin cells, this event was
observed for doses higher than 100 kJ/m2, 10 times more than
the dose we used (Kappes et al., 2006).
Our study shows that the EGFR/Akt pathway targets
selectively Chk1, whereas it does not interfere with Chk2 or
with the upstream regulators ATR and ATM. The role of ATM
and ATR in the regulation of Chk phosphorylation has been
extensively documented. Although ATM and ATR have been
considered for a long period of time as essential regulators of
DNA-damage checkpoints through their respective effectors
Chk2 and Chk1, it has been also largely accepted until
recently that cross-regulation of the ATM–Chk2 and
ATR–Chk1 pathways is very limited. In our study, we showed
for the first time that, in human keratinocytes, UVA
influenced Chk1 but not Chk2 phosphorylation. In view of
the current dogma, this result suggests that ATR, but not ATM,
is of concern. However, the lack of cross-regulation between
the ATR–Chk1 and the ATM–Chk2 axis has been strongly
challenged in a recent study that described an ATR-
dependent ATM control in response to UV (Stiff et al.,
2006). Therefore, it appears that Chk1 phosphorylation could
be under control of not only ATR (as recognized previously),
but also ATM. As a matter of fact, we found that the two
kinases are activated by UVA in HaCaT cells. However, in
view of the above considerations, it is likely that, under our
experimental conditions, ATR is the major regulator of Chk1.
According to the model we propose, it is possible that the
function of ATR could be also important to modulate the
inhibitory effect of the EGFR pathway against Chk1 function.
On the basis of recent studies that have identified functional
polymorphisms of ATR (Durocher et al., 2006), it is thus
conceivable that the unfavorable polymorphism profile
synergizes with the EGFR pathway to abrogate the G2/M
control and therefore increase the presumed mutagenic risk
due to cellular bypass.
Our study shows that the activation of the EGFR pathway
by UVA is a potent regulator of G2/M function by interfering
with Chk1 function. On the basis of this finding, one can
reasonably speculate that more intense and/or more durable
signaling capable of activating the EGFR/Akt pathway, as an
oncogenic product, should be much more efficient at
subverting premitotic control in irradiated cells. In this
perspective, it is interesting to note that previous studies
have identified increased expression of EGFR in squamous-
cell carcinoma (Kamata et al., 1986), perhaps through gene
amplification (Shimizu et al., 2001). Therefore, it is quite
conceivable that, under these pathological conditions, EGFR
overexpression and subsequent amplified EGFR signal exert
similar effects against Chk1 control and synergize with UV
irradiation to abolish mitotic entry control and subsequent
mutagenic risk.
In conclusion, our study shows that UVA-induced EGFR
activation results in serious functional alterations in the
ATR–Chk1 axis resulting in G2/M bypass. This mechanism
could facilitate the accumulation of DNA damage and
therefore could represent an important contributor to photo-
carcinogenesis. Moreover, because of the number of signal-
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Figure 5. Influence of EGFR/Akt pathway on NHK cell-cycle arrest after
UVA irradiation. (a) NHK cells were pretreated or not (NT) with AG1478
(10mM) for 1 hour before UVA irradiation at 0 (NI), 10, 20, or 40 kJ/m2. Cell
cycle was analyzed by flow cytometry 16 hours after irradiation. Histograms
of flow-cytometric analysis show cell cycle of survival population. (b–c) NHK
cells were pretreated or not with AG1478 (10 mM) for 1 hour before UVA
irradiation at 40 kJ/m2. Cells were then incubated for 1 hour. Western-blot
analysis was performed using (b) anti-phospho-Ser473 Akt and anti-Akt Abs
(c) and anti-phospho-Ser345 and anti-phospho-Ser280 Chk1 and anti-Chk1
Abs. These data are representative of three independent experiments.
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ing components involved in this regulation, it is also possible
that the lack of mitotic control could be amplified by other
cellular events such as constitutive activation of the EGFR
pathway or intrinsic deficit of Chk1 regulation (Figure 6).
MATERIALS AND METHODS
Cell culture and chemicals
Immortalized human HaCaT keratinocytes and NHKs were provided
by CERPER (Pierre-Fabre Dermo-Cosme´tique, Toulouse, France).
HaCaT cells were cultured in Dulbecco’s modified Eagle’s medium
at 371C in 5% CO2. Culture medium was supplemented with 10%
fetal calf serum, glutamine (2 mM), streptomycin (100 mg/ml), and
penicillin (200 U/ml). NHKs were obtained from skin explants from
patients undergoing mammary plastic surgery. NHK cells were
cultured in Keratinocyte Serum Free Medium (all these reagents were
purchased from Invitrogen, Cergy Pontoise, France). Written patient
consent was not required for these experiments.
SMARTpool siRNA against Akt1, EGFR, or siControl nontargeting
siRNA were designed by Dharmacon siGENOME (Perbio Science,
Brebieres, France). Transfections of siRNAs (10 nM) were performed
using Oligofectamine and Opti-MEM medium (Invitrogen) according
to the manufacturer’s instructions on cells at 30–50% confluency in
60-mm cell culture dishes and incubated for 48 hours before
experiments. The UVA irradiation source was a fluorescent lamp
(UVITEC, Cambridge, UK) that emitted an energy peak at 365 nm
(filter size, 80 300 mm; 2 15 W tube; wavelength, 365 nm;
intensity at 15 cm, 2300 mW/cm2). The emitted dose was calculated
using a UVA radiometer photodetector (Vilber Lourmat, Marne-la-
valle´e, France). UVA irradiation was performed in cells incubated in
phosphate-buffered saline at 41C.
Drugs and reagents
The rabbit polyclonal antibodies (Abs) against Chk1, Chk1 phos-
phoserine 280, Chk1 phosphoserine 345, Akt, Akt phosphoserine
473, EGFR, Chk2, Chk2 phosphothreonine 68, and phosphotyrosine
PY100 were all used at 1/1000 and were purchased from Cell
Signaling Technology (Ozyme, St Quentin en Yvelines, France). The
mouse monoclonal anti-b-actin Ab (used at 1/1000) was purchased
from NeoMarkers (Interchim, Montluc¸on, France). Affinity-purified
secondary Abs were purchased from Jackson ImmunoResearch
Laboratories, Inc. (Beckman Coulter Company, Roissy CDG,
France). AG1478 was purchased from VWR International (Fontenay-
sous-Bois, France) and propidium iodide was from Invitrogen Life
Technologies (Cergy Pontoise, France). EGF ligand, SB203580,
SP600125, and PD98059 were purchased from Calbiochem (VWR,
Fontenay sous Bois, France). Other products were purchased from
Sigma-Aldrich (St Quentin Fallavier, France).
Western-blot and immunoprecipitation analysis
Cells were washed with cold phosphate-buffered saline and lysed,
after being scraped in lysis buffer containing Cytobuster protein
extraction reagent (VWR), 1 mM EDTA, 1 mM PMSF, 10 mg/ml
leupeptin, for 5 minutes on ice, followed by centrifugation at
13,000 r.p.m. for 5 minutes at 41C. For each lysate, 30 mg of total
protein was boiled for 5 minutes at 951C in the presence of 5% b-
mercaptoethanol. Proteins were separated using 10% SDS-PAGE
and transferred onto nitrocellulose membranes (Amersham Pharma-
cia Biotech, Saclay, France). Nonspecific binding to the membrane
was blocked for 1 hour at room temperature with 10% nonfat milk in
phosphate-buffered saline containing 0.1% Tween 20 (PBST).
Membranes were incubated overnight at 41C with specific primary
antibody diluted at an appropriate concentration in PBST containing
1% nonfat milk. Membranes were then washed three times at room
temperature, and bound immunoglobulins were detected with
horseradish peroxidase-conjugated secondary Ab for 30 minutes at
room temperature in 1% nonfat milk dissolved in PBST. Membranes
were then washed with PBST, and the bound Abs were detected by
the enhanced chemiluminescence system ECL (Amersham Pharma-
cia Biotech, Saclay, France). For immunoprecipitation, cells were
lysed with buffer containing Cytobuster protein extraction reagent
(VWR), 1 mM EDTA, 1 mM PMSF, and 10mg/ml leupeptin. Cell
extracts were then incubated overnight at 41C with anti-EGFR Ab at
1/100. Western-blot analysis was then performed.
Cell-cycle analysis
About 5 105 cells were irradiated, and 16 hours later, they were
harvested by trypsinization and then fixed in 70% ethanol for
15 minutes at room temperature. Cells were then washed with
phosphate-buffered saline, resuspended in propidium iodide (50mg/
ml), and treated for 15 minutes at room temperature with 0.1 mg/ml
RNAse A. Cell-cycle analysis was performed by flow cytometry
using the Winmdi program on a FACScan (Becton Dickson, Le Pont-
De-Claix, France).
Cell viability
Cell viability was evaluated by counting cells using trypan blue
exclusion.
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Figure 6. Hypothetical model: a role of EGFR/Akt pathway in dysregulation
G2/M checkpoint after UVA. UVA irradiation activates both EGFR/Akt and
ATR/ATM pathways. The EGFR/Akt pathway facilitates Ser280
phosphorylation of Chk1, rendering this kinase less susceptible to
ATM/ATR-mediated phosphorylation at stimulatory sites (Ser317 and Ser345).
Changes in Chk1 phosphorylation profile result in the abrogation of Chk1
function, G2/M bypass and survival.
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